Paper33166183
Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?
Mannon EC and 1 other. Am J Physiol Renal Physiol, 2020. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection? Papers, record 33166183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33166183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acid-Base Equilibrium | Major topic |
| Acidosis | Major topic |
| Alkalies | Major topic |
| Kidney | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Sodium Bicarbonate | Major topic |
| Glomerular Filtration Rate | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL134604 | NHLBI NIH HHS | United States | P01HL134604 | PubMed and NIH | NIH RePORTER |
| R21 AI150723 | NIAID NIH HHS | United States | R21AI150723 | PubMed and NIH | NIH RePORTER |
References143
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19190678 | Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass. | Kidney Int | 2009 | https://conductscience.org/library/papers/19190678 | PubMed |
| 2 | 21738953 | Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. | Mol Med | 2011 | https://conductscience.org/library/papers/21738953 | PubMed |
| 3 | 18287403 | Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis. | Am J Physiol Renal Physiol | 2008 | https://conductscience.org/library/papers/18287403 | PubMed |
| 4 | 1987013 | Salt sensitivity. Definition, conception, methodology, and long-term issues. | Hypertension | 1991 | https://conductscience.org/library/papers/1987013 | PubMed |
| 5 | 15345494 | Ammonia production and secretion by S3 proximal tubule segments from acidotic mice: role of ANG II. | Am J Physiol Renal Physiol | 2004 | https://conductscience.org/library/papers/15345494 | PubMed |
| 6 | 6303178 | Effect of chloride on renin and blood pressure responses to sodium chloride. | Ann Intern Med | 1983 | https://conductscience.org/library/papers/6303178 | PubMed |
| 7 | 29882800 | Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials. | Nutrients | 2018 | https://conductscience.org/library/papers/29882800 | PubMed |
| 8 | 19816174 | Acid-base regulation of angiotensin receptors in the kidney. | Curr Opin Nephrol Hypertens | 2010 | https://conductscience.org/library/papers/19816174 | PubMed |
| 9 | 24647050 | KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. | Am J Kidney Dis | 2014 | https://conductscience.org/library/papers/24647050 | PubMed |
| 10 | 26789417 | Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study. | Am J Nephrol | 2015 | https://conductscience.org/library/papers/26789417 | PubMed |
| 11 | 10760100 | Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation. | Kidney Int | 2000 | https://conductscience.org/library/papers/10760100 | PubMed |
| 12 | 15339976 | Increased endothelin activity mediates augmented distal nephron acidification induced by dietary protein. | J Am Soc Nephrol | 2004 | https://conductscience.org/library/papers/15339976 | PubMed |
| 13 | 14675052 | Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat. | Kidney Int | 2004 | https://conductscience.org/library/papers/14675052 | PubMed |
| 14 | 10752529 | Complement activation products in the urine from proteinuric patients. | J Am Soc Nephrol | 2000 | https://conductscience.org/library/papers/10752529 | PubMed |
| 15 | 11413164 | Endothelin-1/endothelin-B receptor-mediated increases in NHE3 activity in chronic metabolic acidosis. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11413164 | PubMed |
| 16 | 30616018 | A basic solution to activate the cholinergic anti-inflammatory pathway via the mesothelium? | Pharmacol Res | 2019 | https://conductscience.org/library/papers/30616018 | PubMed |
| 17 | 30857647 | Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial. | Lancet | 2019 | https://conductscience.org/library/papers/30857647 | PubMed |
| 18 | 27770799 | Correction of metabolic acidosis improves insulin resistance in chronic kidney disease. | BMC Nephrol | 2016 | https://conductscience.org/library/papers/27770799 | PubMed |
| 19 | 19608703 | Bicarbonate supplementation slows progression of CKD and improves nutritional status. | J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19608703 | PubMed |
| 20 | 24851027 | Alkali therapy attenuates the progression of kidney injury via Na/H exchanger inhibition in 5/6 nephrectomized rats. | J Korean Med Sci | 2014 | https://conductscience.org/library/papers/24851027 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938257 | Association Between Urine pH and Kidney Outcomes in Patients with Biopsy-Proven Kidney Disease. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42938257 | PubMed |
| 42529231 | Trajectories of Serum Total Carbon Dioxide and the Risk of Cardiorenal Outcomes in Chronic Kidney Disease: Results From the KNOW-CKD Study. | Kidney Med | 2026 | https://conductscience.org/library/papers/42529231 | PubMed |
| 40691045 | Macula densa nitric oxide synthase 1β restoration by kidney alkalization enhances renal graft outcomes. | Am J Physiol Renal Physiol | 2025 | https://conductscience.org/library/papers/40691045 | PubMed |
| 38279993 | Metabolic acidosis in chronic kidney disease: mere consequence or also culprit? | Pflugers Arch | 2024 | https://conductscience.org/library/papers/38279993 | PubMed |
| 37251318 | Effect of sodium bicarbonate on cardiovascular outcome and mortality in patients with advanced chronic kidney disease. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37251318 | PubMed |
| 36240220 | Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes. | PLoS One | 2022 | https://conductscience.org/library/papers/36240220 | PubMed |
| 35379002 | Comparison of the surgical resection and infarct 5/6 nephrectomy rat models of chronic kidney disease. | Am J Physiol Renal Physiol | 2022 | https://conductscience.org/library/papers/35379002 | PubMed |
| 35176947 | Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis. | Ren Fail | 2022 | https://conductscience.org/library/papers/35176947 | PubMed |
| 35001662 | Acid-base effects of combined renal deletion of NBCe1-A and NBCe1-B. | Am J Physiol Renal Physiol | 2022 | https://conductscience.org/library/papers/35001662 | PubMed |
| 34908841 | The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis. | Ther Clin Risk Manag | 2021 | https://conductscience.org/library/papers/34908841 | PubMed |
| 34718761 | Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease. | Nephrol Dial Transplant | 2021 | https://conductscience.org/library/papers/34718761 | PubMed |
| 34363606 | A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease. | Drugs | 2021 | https://conductscience.org/library/papers/34363606 | PubMed |
| 34313978 | Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies. | Drugs | 2021 | https://conductscience.org/library/papers/34313978 | PubMed |
| 33961145 | Update on Treatment of Hypertension After Renal Transplantation. | Curr Hypertens Rep | 2021 | https://conductscience.org/library/papers/33961145 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33166183
GET https://conductscience.org/api/papers/v1/33166183/references?page=2